Endurance GB has confirmed a positive test for Phenylbutazone in a horse competing at a National Ride in the UK this summer.
The positive test occurred as part of the British Equestrian Federation’s ongoing programme of spot checks. The horse was competing in a 40km Novice Graded Endurance Ride (GER).
The person responsible in the case has accepted the administrative penalty and this is now being processed by the BEF.
Esther Young, Endurance GB operations director said: “In line with the other BEF competitive disciplines, Endurance GB is signed up to the BEF’s Equine Anti-Doping and Controlled Medication Rules (BEFAR). The BEF, under BEFAR, carries out spot checks and regular testing across BEF affiliated events.
“This case serves as a reminder to all riders competing in our sport that they must understand and comply fully with the British Equestrian Federation (BEF) guidelines on medication. Clean sport is an Endurance GB priority at all levels.”
BEFAR guidance
The BEF’s equine anti-doping and controlled medication rules, known as BEFAR, apply to all horses and ponies competing at any level under national rules in the FEI sports of dressage, driving, endurance, eventing, para dressage, showjumping, reining and vaulting.
BEFAR are, so far as is possible, a replica of the Federation Equestre Internationale’s (FEI) equine anti-doping and controlled medication regulations (EADCMR), in order for Great Britain to continue to participate on the world stage in the FEI disciplines.
This includes the adoption of the full FEI Equine Prohibited Substances List, as amended by the FEI from time to time, and its application to all horses and ponies competing in any competition affiliated to one of the FEI member bodies at any level.
Don’t miss the latest issue of Your Horse Magazine, jam-packed with training and veterinary advice, horse-care tips and the latest equestrian products available on shop shelves, on sale now.
